Number of Patients by Best Clinical Response [clinicaltrials_resource:NCT00818649/outcome/1]
outcome [clinicaltrials_vocabulary:outcome]
Number of Patients by Best Clinical Response [clinicaltrials_resource:NCT00818649/outcome/1]
Bio2RDF identifier
NCT00818649/outcome/1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:NCT00818649/outcome/1
group [clinicaltrials_vocabulary:group]
measure [clinicaltrials_vocabulary:measure]
population [clinicaltrials_vocabulary:population]
Evaluable patients are defined ...... had myelodysplastic syndrome.
safety issue [clinicaltrials_vocabulary:safety-issue]
time frame [clinicaltrials_vocabulary:time-frame]
At Completion of Course 3 (Day 63)
Pre-Study and After 3 Cycles
type [clinicaltrials_vocabulary:type]
alternate
Number of Patients by Best Clinical Response
@en
identifier
clinicaltrials_resource:NCT00818649/outcome/1
title
Assessed by the International ...... idered evaluable for response.
@en
type
label
Number of Patients by Best Cli ...... esource:NCT00818649/outcome/1]
@en